Precipio (NASDAQ:PRPO) is scheduled to release its earnings data after the market closes on Wednesday, August 21st.
Precipio (NASDAQ:PRPO) last posted its earnings results on Thursday, May 16th. The biotechnology company reported ($0.48) EPS for the quarter. Precipio had a negative net margin of 533.37% and a negative return on equity of 92.71%. The business had revenue of $0.71 million for the quarter.
Shares of Precipio stock traded down $0.18 during trading hours on Wednesday, reaching $2.70. 89,990 shares of the company’s stock were exchanged, compared to its average volume of 667,118. Precipio has a 1 year low of $1.65 and a 1 year high of $10.80. The firm has a fifty day moving average price of $3.05. The company has a quick ratio of 0.13, a current ratio of 0.14 and a debt-to-equity ratio of 0.09.
Separately, ValuEngine raised shares of Precipio from a “hold” rating to a “buy” rating in a report on Thursday, August 1st.
Precipio, Inc, a cancer diagnostics company, provides diagnostic products and services to the oncology market. It also develops a platform to eradicate the problem of misdiagnosis within academic institutions. In addition, the company delivers diagnostic information to physicians and their patients. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, as well as PerkinElmer.
Featured Story: What is meant by buying and selling pressure?
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.